In a multicenter feasibility study, Matrix Cell Research Insitute Inc.’s magnetic probe TAKUMI was used in conjunction with Hakko Co., Ltd.’s magnetic Guiding-Marker System®, to verify the effectiveness of a magnetic guiding localization system with ultrasound guidance for both detection and excision of non-palpable breast lesions. The article “Magnetically Guided Localization Using a Guiding-Marker System® and… Read More: MOLL Feasibility Study with TAKUMI »
Ongoing research proved that TAKUMI is not only effective in minimally-invasive sentinel lymph node biopsies, but also in magnetically-guided localization of occult lesions (MOLL). Matrix Cell Research Insitute Inc. has therefore added this medical procedure to TAKUMI’s scope of application and expanded the magnetic probe’s CE Marking certificate accordingly. Here are two clinical reports for… Read More: CE Marking Expansion to MOLL with TAKUMI »
TAKUMI – Matrix Cell Research Institute Inc.’s magnetic probe for sentinel lymph node detection – will be exhibited at the 3rd Medical Devices & Hospital Equipment Expo held at Makuhari Messe, Chiba, Japan from October 14 to 16. The company is particularly interested in exploring opportunities for building long-term business relationships. Please make sure to… Read More: TAKUMI at Medical Japan »
Mikio Shiozawa, from the Department of Surgery at Jichi Medical University, shortly describes a feasibility study on magnetic resonance lymphography of sentinel lymph nodes (SLN) in breast cancer patients using superparamagnetic iron oxide (SPIO): To further advance the SLN biopsy technique using SPIOs, we evaluated preoperative SPIO-MR sentinel lymphography to facilitate accurate identification of the… Read More: MR Lymphography of SLN using SPIO »
Breast cancer is one of the most common tumors not only in humans, but also in dogs. The choice of treatment is also similar: surgical resection and metastatic lymph node removal. In some cases, lymph node mapping can be performed via pre-operative CT examination, however, an intraoperative SLN identification method has yet to be established… Read More: Magnetic Detection of SLN in Veterinary Medicine »
Matrix Cell Research Inc.’s Quality Management System (QMS) conforms with the international standard ISO13485, which specializes in the medical device industry and has been adopted as the base of quality control methods for medical devices worldwide. QMS covers a wide range of processes – from design and development to purchasing, manufacturing, inspection, as well as… Read More: TAKUMI – Manufactured Under Strict Quality Control »
The second key component of TAKUMI, the magnetic probe for sentinel lymph node identification, is a Hall sensor. Why choose a Hall sensor over other high precision magnetic flux sensors? The reason for that is the permanent magnet. The magnetic sensor has to be positioned at a specific point: on the center axis of the… Read More: The Hall Sensor – A Key Component of TAKUMI »
This publication covers the recent trend towards employing magnetic nanoparticles in a variety of medical applications, aiming to bring professionals in medicine and scientific researchers closer together to further advance and explore the possibilities in this field. Performing sentinel lymph node biopsies by employing magnetic nanoparticles in conjunction with a magnetic probe is the subject… Read More: IOP eBook: Magnetic Nanoparticles for Medical Diagnostics »
Drs. Kisyo Mihara and Sachiko Matsuda, lecturers at the Keio University School of Medicine, briefly summarize their presentation of a novel tracer imaging for SLN-navigated laparoscopic surgery in gallbladder cancer during the 74th General Meeting of the Japanese Society of Gastroenterological Surgery Conference (Session title: Significance and future prospects of navigation surgery for hepato-pancreato-biliary surgery, July 28, 2019): “The aim of… Read More: Magnetic Tracer Imaging in Laparoscopic Surgery »
While sentinel lymph node biopsy (SLNB) of axillary lymph nodes has become standard practice for the staging and treatment in early breast cancer, SLNB of parasternal lymph nodes has yet to be established as a routine performance due to its lack of clinical relevance. Possibly because its effectiveness has only been studied in axillary lymph… Read More: SLNB in Axillary Lymph Node-Positive Breast Cancer »